Ste. Anne's Hospital (French: Hôpital Sainte-Anne) is a hospital located in Sainte-Anne-de-Bellevue, Quebec, Canada. It primarily serves veterans of the Canadian Forces and is specialized in long-term and geriatric care. It also treats younger veterans for operational stress injuries and post-traumatic stress disorder. The hospital has 446 beds in private rooms and underwent an extensive renovation in 2009.
OBJECTIVES:This World Federation of Societies of Biological Psychiatry (WFSBP) consensus paper aims to summarise and evaluate the published study results on objectively measurable biological markers associated with anorexia nervosa (AN). METHODS:The relevant literature was reviewed by the WFSBP Task Forces on Eating Disorders and on Biological Markers, and a consensus regarding the significance of the published evidence was reached. RESULTS:Candidate biological markers that have been associated with AN include clinical (e.g. body weight), molecular (e.g. genetic, epigenetic, hormonal, immunological, metabolomic), cellular (e.g. leukocytes), neuroimaging (e.g. structure, function, connectivity), digital, cardiac and neurophysiological parameters. Some clinical and laboratory parameters are risk markers in clinical practice. Biological markers have pathophysiological relevance in understanding the biological and metabolic pathophysiology of AN and its physical health consequences. Few studies have examined pharmacogenetics or therapeutic drug monitoring as tools to monitor and guide the treatment of AN. CONCLUSIONS:Biological markers will hopefully soon enable clinicians to intervene earlier in a more targeted manner to mitigate treatment resistance. However, the current scientific basis for most biological markers are group comparisons only. Studies on sensitivity, specificity and the prognostic value of these markers are lacking.
Over the last four decades, studies provided evidence that individuals tend to rate statements as being more truthful when they are re-exposed to them, the so-called 'illusory truth effect'. In light of a growing number of studies published since the previous meta-analysis in 2006 and concern of publishing biases, we conduct a meta-analysis on 182 studies and 366 effect sizes (N = 31,184 participants) published from 1977 to 2025. After correcting for small-study effects, we observe a small illusory truth effect (g = 0.37, 95% confidence interval [0.30, 0.44]), with a substantial within and between-study heterogeneity. Here, we show that multiple variables accounted for such heterogeneity, including the type of item, the instructions during the first exposure, the presence of veracity cues, and the duration of presentation on first exposure to the statement. We highlight the importance of the initial exposure and discuss practical implications regarding the current misinformation crisis.
In glioblastoma surgery, neurosurgeons must balance the oncologic benefit of maximal safe cytoreduction against the risk of postoperative morbidity. We evaluated surgery-related complications, unplanned readmission, and functional outcomes, and assessed whether reoperation, awake mapping, or greater extent of resection increase morbidity. We performed a retrospective single-center study of 839 adults who underwent supratentorial glioblastoma resections (first-line or recurrent) between 2000 and 2024. Primary endpoints were regional or systemic complications within 90 days, unplanned readmission within 30 days, ≥ 30-point KPS score decline, and KPS score < 70 at three postoperative months. Multivariable logistic regression identified independent predictors of postoperative morbidity, with particular focus on surgical strategies (reoperation, awake mapping, extent of resection). Surgery-related morbidity was infrequent. Across all models, increased odds of complications, readmission, or functional decline were independently associated with older age, frailty, baseline KPS score < 70, larger tumor volume, midline mass effect, multilobar involvement, tumor-related epilepsy, and preoperative neurological deficit. In contrast, reoperation, awake craniotomy, and greater extent of resection were not associated with higher complications, readmission, or functional decline rates. In this large contemporary cohort, durable postoperative morbidity was determined primarily by baseline physiological reserve (frailty, low KPS score, preoperative deficits) and disease burden (volume, multilobar spread, midline crossing), whereas reoperation, awake mapping, and maximal resection were not. These findings support frailty-informed selection and function-preserving maximal safe resection to preserve independence, enable timely adjuvant therapy, and ultimately improve survival in glioblastoma patients.
Burnout syndrome (BOS) represents an enduring challenge for preventive medicine. While biomarkers of chronic stress have been explored within the allostatic load framework, BOS lacks a consistent physiological signature, hindering early and comprehensive identification of individuals at risk. This systematic review synthesises current evidence on BOS-related biomarkers, aiming to identify potential physiological correlates. We conducted a comprehensive search of PubMed and EMBASE, yielding 111 studies evaluating 36 biomarkers in adult populations. Our analysis revealed inconsistent associations across most physiological systems, including the hypothalamic-pituitary-adrenal axis (e.g., cortisol, DHEA), the immune system, and cardiovascular parameters. While some biomarkers such as HbA1c and blood glucose showed relatively more consistent associations with BOS, the overall findings remain largely inconclusive. Overall, the current biological evidence is insufficient to identify a BOS biosignature that could support routine clinical diagnosis. Future research should prioritise a more unified and comprehensive definition of BOS and investigate physiological patterns within more standardized research frameworks to advance objective identification and prevention strategies.